KORU Medical SystemsKRMD -3.49%76 PB Ratio is 12.07 as of Jul. 08, 2026, which is 109% above its 10-year median of 5.77. GuruFocus rates KRMD with a GF Score™ of 76/100 and a GF Value™ of $4.08 (Fairly Valued). Among 787 Medical Devices & Instruments companies, KORU Medical Systems ranks worse than 93.77% on this metric.
The historical rank and industry rank for KORU Medical Systems's PB Ratio or its related term are showing as below:
KRMD'
s PB Ratio Range Over the Past 10 Years
Min: 1.99 Med: 5.77 Max: 37.58
Current: 11.97
During the past 13 years, KORU Medical Systems's highest PB Ratio was 37.58. The lowest was 1.99. And the median was 5.77.
KRMD's PB Ratio is ranked worse than 93.77% of 787
companies
in the Medical Devices & Instruments industry
Industry Median: 2.06
vs KRMD: 11.97
During the past 12 months, KORU Medical Systems's average Book Value Per Share Growth Rate was 3.70% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -18.90% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -18.00% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 12.20% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of KORU Medical Systems was 67.80% per year. The lowest was -52.50% per year. And the median was 16.30% per year.
Back to Basics: PB Ratio
KORU Medical Systems (NAS:KRMD) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
KORU Medical Systems PB Ratio Related Terms
KORU Medical Systems PB Ratio Historical Data
* Premium members only.
The historical data trend for KORU Medical Systems's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, KORU Medical Systems's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
KORU Medical Systems PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, KORU Medical Systems's PB Ratio distribution charts can be found below:
* The bar in red indicates where KORU Medical Systems's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
KORU Medical Systems (KRMD) has a PB Ratio of 12.07 as of Jul. 08, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on KORU Medical Systems and its competitors. This is 109% above median its historical median of 5.77. Over the past decade, KORU Medical Systems' PB Ratio has ranged from 1.99 to 37.58. According to the industry distribution chart, KORU Medical Systems ranks #738 out of 787 companies in the Medical Devices & Instruments industry, placing it in the top 93.8%.
Is KORU Medical Systems' PB Ratio too high?
KORU Medical Systems' current PB Ratio of 12.07 is 109% above median its 10-year median of 5.77. Over the past 10 years, this metric has ranged from a low of 1.99 to a high of 37.58. The Medical Devices & Instruments industry median PB Ratio is 2.06. KORU Medical Systems' value of 12.07 is 485.9% above this industry median. Based on the distribution chart, KORU Medical Systems ranks #738 out of 787 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, KORU Medical Systems has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does KORU Medical Systems' PB Ratio compare to EMBC and PDEX?
According to the Medical Devices & Instruments industry distribution chart, KORU Medical Systems ranks #738 out of 787 companies for PB Ratio. This places KORU Medical Systems in the lower half of its industry. The industry median PB Ratio is 2.06. KORU Medical Systems' value of 12.07 is 485.9% above this benchmark. Historically, KORU Medical Systems' own PB Ratio has ranged from 1.99 to 37.58 over the past decade. While the company's 10-year median is 5.77 vs. the industry median of 2.06, KORU Medical Systems has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.06, based on 787 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. KORU Medical Systems's current PB Ratio of 12.07 is 485.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on KORU Medical Systems and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. KORU Medical Systems's current PB Ratio is 12.07, which is 109% above median its own 10-year median of 5.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KORU Medical Systems stock overvalued right now?
Based on GuruFocus' analysis, KORU Medical Systems (KRMD) is currently considered Fairly Valued. The stock's GF Value™ is $4.08, compared to a current price of $4.43 — trading 8.6% above its estimated fair value. The current PB Ratio is 12.07, which is 109% above median its 10-year median of 5.77 and 485.9% above the Medical Devices & Instruments industry median of 2.06. KORU Medical Systems' overall GF Score™ is 76/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For KORU Medical Systems (KRMD), the current PB Ratio is 12.07 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is KORU Medical Systems (KRMD) Overvalued in 2026?
Based on GuruFocus' analysis, KORU Medical Systems stock appears to be overvalued.
The current stock price of $4.43 is trading 8.6% above its estimated GF Value™ of $4.08.
GuruFocus considers KORU Medical Systems to be Fairly Valued.
Key valuation signals for KRMD:
PB Ratio: 12.07 (109% above median its 10-year median of 5.77)
GF Value™: $4.08 vs. price of $4.43 (8.6% above fair value)
Industry Position: 485.9% above the Medical Devices & Instruments median (#738 of 787)
No single metric tells the full story. See the KRMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.
76GF Score
Get the complete analysis for KRMD
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KRMD has been successfully added to your 
